Table 1 |
||||||||
|
Proteins identified in the secretome of IL-1β-stimulated chondrocytes with or without CS treatment |
||||||||
|
Symbol |
Score |
Peptides (95%) |
Covariance (%) |
Accession numbera |
Name |
Function |
OA serum [22] |
OA synovial fluid [23] |
|
|
||||||||
|
MMP2 |
20.24 |
17 |
36.4 |
[P08253] |
72 kDa type IV collagenase |
Angiogenesis/collagen degradation |
x |
|
|
A1AT |
2 |
2 |
6 |
[P01009] |
Alpha-1-antitrypsin |
Inhibitor of serine proteases |
||
|
ANXA2 |
2 |
1 |
36 |
[P07355] |
Annexin A2 |
Heat-stress response |
||
|
B2MG |
4 |
3 |
26.9 |
[P61769] |
Beta-2-microglobulin |
Immunity |
x |
|
|
PGS1 |
4.03 |
3 |
13.9 |
[P21810] |
Biglycan |
Collagen fiber assembly/ECM component |
||
|
CATB |
3.06 |
2 |
15.3 |
[P07858] |
Cathepsin B |
Thiol protease |
||
|
CCL2 |
6 |
4 |
38.4 |
[P13500] |
C-C motif chemokine 2b |
Inflammatory response |
||
|
CCL8 |
4 |
2 |
38.4 |
[P80075] |
C-C motif chemokine 8b |
Inflammatory response |
||
|
CH3L1 |
63.26 |
96 |
82 |
[P36222] |
Chitinase-3-like protein 1 |
ECM component |
x |
|
|
CH3L2 |
2 |
2 |
17.7 |
[Q15782] |
Chitinase-3-like protein 2b |
ECM component |
||
|
CLUS |
10.09 |
9 |
43.2 |
[P10909] |
Clusterin |
Immunity |
x |
x |
|
CCD80 |
2 |
1 |
23.3 |
[Q76M96] |
Coiled-coil domain-containing protein 80 |
Cell adhesion and matrix assembly |
||
|
CO3A1 |
2.02 |
1 |
14.3 |
[P02461] |
Collagen alpha-1(III) chain |
ECM component |
||
|
CO6A1 |
4.16 |
4 |
28.5 |
[P12109] |
Collagen alpha-1(VI) chain |
ECM component |
||
|
COCA1 |
17.35 |
10 |
21.1 |
[Q99715] |
Collagen alpha-1(XII) chain |
ECM component |
||
|
CO1A2 |
27.65 |
25 |
55.2 |
[P08123] |
Collagen alpha-2(I) chain |
ECM component |
||
|
C1R |
8.13 |
7 |
31.5 |
[P00736] |
Complement C1r subcomponent |
Immunity |
x |
x |
|
C1S |
10.6 |
9 |
27.3 |
[P09871] |
Complement C1s subcomponent |
Immunity |
x |
x |
|
CO3 |
13.4 |
7 |
26.4 |
[P01024] |
Complement C3 |
Immunity |
x |
|
|
CFAB |
8.29 |
6 |
17.2 |
[P00751] |
Complement factor B |
Immunity |
x |
x |
|
CXCL3 |
4.01 |
4 |
69.2 |
[P19876] |
C-X-C motif chemokine 3b |
inflammatory response |
||
|
CXCL5 |
2 |
1 |
20.2 |
[P42830] |
C-X-C motif chemokine 5b |
Inflammatory response |
||
|
CXCL6 |
4.13 |
5 |
38.6 |
[P80162] |
C-X-C motif chemokine 6b |
Inflammatory response |
||
|
CYTC |
4 |
3 |
67.1 |
[P01034] |
Cystatin-C |
Inhibitor of cysteine proteinases |
x |
|
|
PGS2 |
23.72 |
22 |
56 |
[P07585] |
Decorin |
ECM component |
||
|
DESP |
2 |
1 |
24.8 |
[P15924] |
Desmoplakinb |
Cell junction |
x |
|
|
FBLN3 |
15.7 |
12 |
31.2 |
[Q12805] |
EGF-containing fibulin-like extracellular matrix protein 1 |
Negative regulator of chondrocyte differentiation |
x |
x |
|
FINC |
152.34 |
150 |
58.9 |
[P02751] |
Fibronectin |
ECM component |
x |
x |
|
FBLN1 |
2 |
1 |
11.2 |
[P23142] |
Fibulin-1 |
Cell adhesion/ECM organization |
x |
|
|
FSTL1 |
2.1 |
2 |
16.2 |
[Q12841] |
Follistatin-related protein 1 |
Cell proliferation and differentiation |
||
|
GDN |
24.73 |
23 |
54.5 |
[P07093] |
Glia-derived nexin |
Serine protease inhibitor |
||
|
GROA |
4 |
5 |
54.2 |
[P09341] |
Growth-regulated alpha protein |
Inflammatory response |
||
|
IBP3 |
12.02 |
12 |
57.7 |
[P17936] |
Insulin-like growth factor-binding protein 3 |
Cell proliferation and differentiation |
x |
|
|
IBP4 |
3.36 |
3 |
37.6 |
[P22692] |
Insulin-like growth factor-binding protein 4 |
Cell proliferation and differentiation |
||
|
IBP5 |
4.03 |
2 |
55.5 |
[P24593] |
Insulin-like growth factor-binding protein 5 |
Cell proliferation and differentiation |
||
|
IBP6 |
3.85 |
3 |
43.8 |
[P24592] |
Insulin-like growth factor-binding protein 6 |
Cell proliferation and differentiation |
x |
|
|
IBP7 |
2.15 |
3 |
29.1 |
[Q16270] |
Insulin-like growth factor-binding protein 7 |
Cell proliferation and differentiation |
||
|
IL6 |
16 |
16 |
42 |
[P05231] |
IL-6 |
Inflammatory response |
||
|
IL8 |
4.24 |
6 |
57.6 |
[P10145] |
IL-8 |
Inflammatory response |
||
|
MMP1 |
35.12 |
38 |
50.1 |
[P03956] |
Interstitial collagenase |
Collagen degradation |
||
|
K1C10 |
60.82 |
36 |
66.8 |
[P13645] |
Keratin, type I cytoskeletal 10 |
Intermediate filament |
x |
x |
|
K1C14 |
11.36 |
7 |
44.9 |
[P02533] |
Keratin, type I cytoskeletal 14b |
Intermediate filament |
||
|
K1C16 |
15.45 |
8 |
48 |
[P08779] |
Keratin, type I cytoskeletal 16b |
Intermediate filament |
||
|
K1C9 |
30.98 |
19 |
60.2 |
[P35527] |
Keratin, type I cytoskeletal 9 |
Intermediate filament |
x |
x |
|
K2C1 |
70.89 |
41 |
69.6 |
[P04264] |
Keratin, type II cytoskeletal 1 |
Intermediate filament |
x |
x |
|
K22E |
43.26 |
22 |
69.2 |
[P35908] |
Keratin, type II cytoskeletal 2 epidermal |
Intermediate filament |
x |
x |
|
K2C6B |
20.77 |
11 |
53.9 |
[P04259] |
Keratin, type II cytoskeletal 6Bb |
Intermediate filament |
x |
|
|
MFGM |
6.01 |
4 |
20.9 |
[Q08431] |
Lactadherin |
Angiogenesis |
||
|
LUM |
28.15 |
30 |
60.7 |
[P51884] |
Lumican |
ECM component |
x |
x |
|
CSF1 |
4.01 |
2 |
17.3 |
[P09603] |
Macrophage colony-stimulating factor 1b |
Inflammatory response |
||
|
TIMP1 |
17.8 |
16 |
57.5 |
[P01033] |
Metalloproteinase inhibitor 1 |
Metalloprotease inhibitor |
x |
|
|
TIMP2 |
4 |
3 |
32.7 |
[P16035] |
Metalloproteinase inhibitor 2 |
Metalloprotease inhibitor |
||
|
PTX3 |
2.02 |
2 |
14.4 |
[P26022] |
Pentraxin-related protein PTX3 |
Inflammatory response |
||
|
PLTP |
5.8 |
4 |
31 |
[P55058] |
Phospholipid transfer protein |
Lipid transport |
x |
x |
|
IC1 |
4 |
2 |
18.8 |
[P05155] |
Plasma protease C1 inhibitor |
Immunity |
x |
x |
|
POTEF |
2.03 |
1 |
27.6 |
[A5A3E0] |
POTE ankyrin domain family member Fb |
Unknown |
||
|
SAP |
2 |
1 |
5 |
[P07602] |
Proactivator polypeptideb |
Lipid metabolism |
||
|
PCOC1 |
5.93 |
4 |
19.8 |
[Q15113] |
Procollagen C-endopeptidase enhancer 1 |
Collagen metabolism |
x |
|
|
S10A8 |
1.54 |
1 |
35.5 |
[P05109] |
Protein S100-A8b |
Inflammatory response |
x |
|
|
S10A9 |
4 |
2 |
34.2 |
[P06702] |
Protein S100-A9b |
Inflammatory response |
x |
|
|
PRG4 |
3.7 |
3 |
21.9 |
[Q92954] |
Proteoglycan 4b |
ECM component |
x |
x |
|
TRY6 |
4 |
2 |
15.4 |
[Q8NHM4] |
Putative trypsin-6b |
Serine protease |
||
|
NPT2C |
2 |
1 |
10.9 |
[Q8N130] |
Sodium-dependent phosphate transport protein 2Cb |
Ion transport |
||
|
SPRC |
2 |
2 |
7.3 |
[P09486] |
SPARC |
Cell proliferation and differentiation |
x |
|
|
MMP3 |
48.64 |
47 |
71.9 |
[P08254] |
Stromelysin-1 |
Collagen degradation |
x |
|
|
QSOX1 |
4.87 |
4 |
16.3 |
[O00391] |
Sulfhydryl oxidase 1 |
Cell redox homeostasis |
x |
|
|
SDC4 |
2 |
1 |
13.6 |
[P31431] |
Syndecan-4 |
ECM component |
||
|
TARSH |
8.86 |
9 |
27.4 |
[Q7Z7G0] |
Target of Nesh-SH3 |
Cell proliferation and differentiation |
x |
|
|
TENA |
13.36 |
8 |
22.5 |
[P24821] |
Tenascin |
Cell adhesion/ECM organization |
||
|
TETN |
4 |
4 |
34.2 |
[P05452] |
Tetranectin |
Bone mineralization |
x |
x |
|
TSP1 |
2.36 |
2 |
18.5 |
[P07996] |
Thrombospondin-1 |
Angiogenesis |
x |
|
|
BGH3 |
2 |
1 |
22.6 |
[Q15582] |
TGF-beta-induced protein ig-h3 |
TGF-beta signaling |
x |
|
|
TSG6 |
28.35 |
30 |
69.3 |
[P98066] |
TNF-inducible gene 6 protein |
Cell adhesion |
||
|
VCAM1 |
2 |
1 |
12.2 |
[P19320] |
Vascular cell adhesion protein 1 |
Cell adhesion |
x |
|
|
VASN |
2 |
2 |
14.7 |
[Q6EMK4] |
Vasorin |
TGF-beta signaling |
x |
|
|
|
||||||||
|
Proteins identified by SILAC and liquid chromatography-mass spectrometry analysis in the secretome of IL-1β-stimulated chondrocytes with or without chondroitin sulfate treatment. ECM, extracellular matrix; EGF, epidermal growth factor; TGF, transforming growth factor. aProtein accession number according to the SwissProt and TrEMBL databases. bProtein not identified in our previous analysis of chondrocyte secretome [12]. |
||||||||
|
Calamia et al. Arthritis Research & Therapy 2012 14:R202 doi:10.1186/ar4040 |
||||||||